Accelerating R&D
16 Nov 2022
Companies in the UK traditionally finance the majority of their innovation either through raising finance via
private equity rounds or by reinvesting company revenue. Both approaches have strong advantages and
disadvantages.
In the UK there are a multitude of different non dilutive funding options to raise large sums of money to invest
into company innovation/R&D and allow companies to accelerate plans.
The seminar will cover an alternative funding strategy for innovative companies via the combination of UK R&D
tax credits, Grants and debt financing.
An effective non-dilutive funding strategy can allow CFO’s and CEO’s to spend more time with their business and
raise cash to finance R&D.
private equity rounds or by reinvesting company revenue. Both approaches have strong advantages and
disadvantages.
In the UK there are a multitude of different non dilutive funding options to raise large sums of money to invest
into company innovation/R&D and allow companies to accelerate plans.
The seminar will cover an alternative funding strategy for innovative companies via the combination of UK R&D
tax credits, Grants and debt financing.
An effective non-dilutive funding strategy can allow CFO’s and CEO’s to spend more time with their business and
raise cash to finance R&D.